The lncRNA PILA promotes NF-κB signaling in osteoarthritis by stimulating the activity of the protein arginine methyltransferase PRMT1

作者：Tang, Su'an; Cao, Yumei; Cai, Zhaopeng; Nie, Xiaoyu; Ruan, Jianzhao; Zhou, Zuoqing; Ruan, Guangfeng; Zhu, Zhaohua^*; Han, Weiyu^*; Ding, Changhai^*

来源：Science signaling, 2022, 15(735): eabm6265.

DOI：10.1126/scisignal.abm6265

• LONG NONCODING RNA
• HELICASE-A
• UNIQUE FEATURES
• METHYLATION
• CHONDROCYTES
• DEGRADATION
• EXPRESSION
• CULTURE
• INJURY

Inflammatory cytokine-induced activation of nuclear factor kappa B (NF-kappa B) signaling plays a critical role in the pathogenesis of osteoarthritis (OA). We identified PILA as a long noncoding RNA (lncRNA) that enhances NF-kappa B signaling and OA. The abundance of PILA was increased in damaged cartilage from patients with OA and in human articular chondrocytes stimulated with the proinflammatory cytokine tumor necrosis factor (TNF). Knockdown of PILA inhibited TNF-induced NF-kappa B signaling, extracellular matrix catabolism, and apoptosis in chondrocytes, whereas ectopic expression of PILA promoted NF-kappa B signaling and matrix degradation. PILA promoted PRMT1-mediated arginine methylation of DExH-box helicase 9 (DHX9), leading to an increase in the transcription of the gene encoding transforming growth factor beta-activated kinase 1 (TAK1), an upstream activator of NF-kappa B signaling. Furthermore, intra-articular injection of an adenovirus vector encoding PILA triggered spontaneous cartilage loss and exacerbated posttraumatic OA in mice. This study provides insight into the regulation of NF-kappa B signaling in OA and identifies a potential therapeutic target for this disease.

• 单位
  1; 南方医科大学; 河北医科大学; 邵阳学院; 中山大学